Table 5.
3‐month follow‐up | 12‐month follow‐up | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | |
BP at ER | ||||||
SBP | 0.987 | 0.978–0.997 | .008 | 0.988 | 0.979–0.998 | .015 |
MAP | 0.985 | 0.971–1 | .046 | 0.983 | 0.968–0.997 | .002 |
BP change | ||||||
ΔSBP | 1 | 0.989–1.012 | .954 | 1.007 | 0.996–1.019 | .213 |
ΔMAP | 0.998 | 0.980–1.017 | .842 | 1.011 | 0.992–1.031 | .259 |
BP, blood pressure; ER, emergency room; SBP, systolic blood pressure; MAP, mean arterial pressure.
Age, sex, NIHSS score in the acute setting, congestive heart failure, diabetes mellitus (type 1 and type 2) and history of ischemic stroke (IS) were used as covariates. In the analyses of ΔSBP and ΔMAP, SBP and MAP, respectively, were also included as covariates.